Treximet -Drug Insights, 2016

Treximet- Drug Insights, 2016" highlights the Treximet marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Treximet covering the total sales estimation and also provides the Treximet sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Treximet, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight's Report provides the SWOT analysis for the Treximet Industry - A review of the Treximet based on information derived from company and industry-specific sources - Coverage of the Marketed data of the Treximet on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification - Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Treximet with location details - Patent Expiry Timeline and Exclusivity Details - Route of Synthesis of the API - Global Forecasted Sales Figure to 2018 - Qualitative and quantitative assessment of market space - SWOT Analysis

Inquire for discount at http://www.rnrmarketresearch.com/contacts/discount?rname=451090

List of Tables

Table 1: Treximet, Historical Global Sales (in million USD), 2016

Table 2: Treximet, Forecasted Global Sales (in million USD), 2016

Table 3: Treximet, Description

Table 4: Treximet, Marketed Details the United States (US)

Table 5: Treximet, Marketed Details the Europe (EU)

Table 6: Treximet, Patent/Exclusivity Expiry (Year), 2016

Table 7: Treximet, Patent Number Specific Patent Expiry (Year), 2016

Table 8: Treximet, Patent Details

Table 9: Treximet, Route of Synthesis

Table 10: Treximet, the United States Drug Master File (US DMF), 2016

Table 11: Treximet, the Europe Active Substance...